4572 Carna Biosciences,Inc.カルナバイオサイエンスTSE Growth / Pharmaceuticals
0 posts
Carna Biosciences,Inc. (4572) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Carna Biosciences,Inc. (4572) Stock Price History
Carna Biosciences,Inc. closed at ¥291 on Nov 20, 2026, −18.0% over 1 month, +39.2% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥81,972 today (−18.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −18.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥291 | −8 | −2.68% |
| Nov 19 (Thu) | ¥299 | −11 | −3.55% |
| Nov 18 (Wed) | ¥310 | −7 | −2.21% |
| Nov 17 (Tue) | ¥317 | −3 | −0.94% |
| Nov 16 (Mon) | ¥320 | +5 | +1.59% |
| Nov 13 (Fri) | ¥315 | −20 | −5.97% |
| Nov 12 (Thu) | ¥335 | −13 | −3.74% |
| Nov 11 (Wed) | ¥348 | −2 | −0.57% |
| Nov 10 (Tue) | ¥350 | +15 | +4.48% |
| Nov 9 (Mon) | ¥335 | +4 | +1.21% |
If you had invested ¥100,000 3 months ago, it would be worth ¥71,499 today (−28.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −28.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥291 | −8 | −2.68% |
| Nov 19 (Thu) | ¥299 | −11 | −3.55% |
| Nov 18 (Wed) | ¥310 | −7 | −2.21% |
| Nov 17 (Tue) | ¥317 | −3 | −0.94% |
| Nov 16 (Mon) | ¥320 | +5 | +1.59% |
| Nov 13 (Fri) | ¥315 | −20 | −5.97% |
| Nov 12 (Thu) | ¥335 | −13 | −3.74% |
| Nov 11 (Wed) | ¥348 | −2 | −0.57% |
| Nov 10 (Tue) | ¥350 | +15 | +4.48% |
| Nov 9 (Mon) | ¥335 | +4 | +1.21% |
If you had invested ¥100,000 6 months ago, it would be worth ¥66,897 today (−33.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −33.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥291 | −19.8% |
| Oct 2026 | ¥363 | −16.0% |
| Sep 2026 | ¥432 | +2.6% |
| Aug 2026 | ¥421 | +38.0% |
| Jul 2026 | ¥305 | −10.3% |
| Jun 2026 | ¥340 | −19.2% |
| May 2026 | ¥421 | +8.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥139,234 today (+39.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +39.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥291 | −19.8% |
| Oct 2026 | ¥363 | −16.0% |
| Sep 2026 | ¥432 | +2.6% |
| Aug 2026 | ¥421 | +38.0% |
| Jul 2026 | ¥305 | −10.3% |
| Jun 2026 | ¥340 | −19.2% |
| May 2026 | ¥421 | +8.5% |
| Apr 2026 | ¥388 | +1.6% |
| Mar 2026 | ¥382 | +16.1% |
| Feb 2026 | ¥329 | −1.5% |
| Jan 2026 | ¥334 | −6.2% |
| Dec 2025 | ¥356 | +56.1% |
| Nov 2025 | ¥228 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥34,155 today (−65.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −65.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥291 | −18.3% |
| 2025 | ¥356 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥30,313 today (−69.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −69.7%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥291 | −18.3% |
| 2025 | ¥356 | ― |
If you had invested ¥100,000 in Apr 2008, it would be worth ¥37,597 today (−62.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +318.6%, while this stock moved −62.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥291 | −18.3% |
| 2025 | ¥356 | +18.7% |
| 2024 | ¥300 | −42.5% |
| 2023 | ¥522 | +0.4% |
| 2022 | ¥520 | −52.8% |
| 2021 | ¥1,102 | −9.1% |
| 2020 | ¥1,212 | −42.9% |
| 2019 | ¥2,123 | +135.9% |
| 2018 | ¥900 | −20.2% |
| 2017 | ¥1,128 | −46.9% |
| 2016 | ¥2,125 | −21.9% |
| 2015 | ¥2,722 | +261.0% |
| 2014 | ¥754 | +1.6% |
| 2013 | ¥742 | +225.4% |
| 2012 | ¥228 | −23.9% |
| 2011 | ¥300 | −25.9% |
| 2010 | ¥404 | −26.9% |
| 2009 | ¥553 | −28.2% |
| 2008 | ¥770 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2008). Please check the latest prices before trading.
Carna Biosciences,Inc. (4572) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Carna Biosciences,Inc. (4572)
Business overview
The company conducts research and development aimed at creating innovative new drugs, with kinases, enzymes that control signaling inside and outside cells, as its main drug targets. When kinases malfunction because of gene mutations, stress or other factors, they are known to lead to cancer, immune and inflammatory diseases such as rheumatoid arthritis, and neurodegenerative diseases such as Alzheimer's disease.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Market cap | ¥6.2 bn | No. 55 in the sector (largest first) |
|---|
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥497 | 1/19 |
|---|---|---|
| 52-week low | ¥207 | 2025/11/25 |
| Current position | 29.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥291) |
| Year to date | -18.3% | No. 44 of 77 in the sector (best first) |
| 1 year | +39.2% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 10/19 (No. 10) |
|---|---|---|
| Top 50 losers | 2 times | Latest: 10/20 (No. 34) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/19 16:00従業員に対する譲渡制限付株式としての新株式発行に関するお知らせ
- 11/09 16:45新株予約権付社債発行プログラム設定契約に基づく第三者割当による第6回無担保転換社債型新株予約権付社債の発行に関するお知らせ
- 11/06 16:00営業外費用及び特別損失の計上に関するお知らせ
- 11/06 16:002026年12月期第3四半期決算短信〔日本基準〕(連結)
- 11/06 16:002026年第3四半期決算説明資料
- 11/04 16:00第三者割当による第5回無担保転換社債型新株予約権付社債の発行に係る払込完了に関するお知らせ
- 11/02 16:00docirbrutinib(AS-1763)開発促進新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 10/19 17:15新株予約権付社債発行プログラム設定契約に基づく第三者割当による第5回無担保転換社債型新株予約権付社債の発行に関するお知らせ
- 10/14 16:00第三者割当による第4回無担保転換社債型新株予約権付社債及び新株式の発行に係る払込完了に関するお知らせ
- 10/05 16:00テキサス大学MDアンダーソンがんセンターとのmonzosertib医師主導治験に係るCTA締結のお知らせ
Show 2 more
- 09/28 16:45新株予約権付社債発行プログラム設定契約の締結及び第三者割当による第4回無担保転換社債型新株予約権付社債並びに新株式の発行に関するお知らせ
- 09/28 16:45資金調達に関する補足説明資料
Filings from the past 12 months (12).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Carna Biosciences,Inc. board
More Japanese stocks in English
- TAIKO PHARMACEUTICAL CO.,LTD.4574
- CanBas Co.,Ltd.4575
- D.Western Therapeutics Institute, Inc.4576
- Daito Pharmaceutical Co.,Ltd.4577
- RaQualia Pharma Inc.4579
- Le Lien Co.,Ltd.457A
- SymBio Pharmaceuticals Limited4582
- Chiome Bioscience Inc.4583
- Kidswell Bio Corporation4584
- Medrx Co.,Ltd.4586
- PeptiDream Inc.4587
- Oncolys BioPharma Inc.4588